Epigentek's Proprietary Epigenetic Technologies Featured in Nature Magazine Publication Published 08/12/2008 |
|||
BROOKLYN, NY - Aug. 12. Epigentek Group Inc., a leader in the field of epigenetic assays and kits, is pleased to announce that its proprietary technologies and products for DNA methylation and histone modification were featured in the newest publication by Nature magazine in an article on the subject of epigenomics. Epigentek was one of the companies interviewed for the article which was published in the August 7 issue of Nature magazine. The well-known science magazine interviewed Dr. Adam Li, the company’s chief scientific officer.
A link to a PDF file of the article can be found at http://www.nature.com/nature/journal/v454/n7205/full/454795b.html. About Nature: Nature is a weekly international journal publishing highly regarded peer-reviewed research in all fields of science and technology and provides authoritative, insightful news and coming trends affecting science, scientists and the wider public. About Epigentek Group Inc: Epigentek Group Inc. is a biotechnology company that focuses on developing and providing innovative technology and products as a complete and systematic solution for epigenetics-related research and drug discovery. The company has developed a comprehensive portfolio of more than 400 proprietary products that are used all around the world by esteemed academia, leading pharmaceuticals, and cutting edge biotechnology companies. These unique products are specifically designed to make assays significantly more simple, fast, convenient and efficient than conventional methods. The company, particularly emphasizing speed and effectiveness in its technologies, continues to focus on epigenetic innovation and to extensively develop and enhance its product portfolio. For more information about Epigentek, please visit http://www.epigentek.com. |
|||
Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpigenTek Group Inc. All rights reserved. |